These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31735780)

  • 1. Feasibility of Uninterrupted Direct Oral Anticoagulants with Temporary Switching to Dabigatran ("Dabigatran Bridge") for Catheter Ablation of Atrial Fibrillation.
    Aoyama D; Miyazaki S; Hasegawa K; Kaseno K; Ishikawa E; Mukai M; Miyahara K; Aiki T; Matsui A; Yamaguchi J; Shiomi Y; Tama N; Ikeda H; Fukuoka Y; Morishita T; Ishida K; Uzui H; Tada H
    Int Heart J; 2019 Nov; 60(6):1315-1320. PubMed ID: 31735780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated clotting time on the day of atrial fibrillation ablation for minimally interrupted and uninterrupted direct oral anticoagulation therapy: Sequential changes, differences among direct oral anticoagulants, and ablation safety outcomes.
    Yamaji H; Murakami T; Hina K; Higashiya S; Kawamura H; Murakami M; Kamikawa S; Hirohata S; Kusachi S
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2823-2833. PubMed ID: 31701593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose dabigatran versus uninterrupted acenocoumarol for peri-procedural anticoagulation in atrial fibrillation catheter ablation.
    Efremidis M; Vlachos K; Letsas KP; Giannopoulos G; Lioni L; Georgopoulos S; Vadiaka M; Deftereos S; Sideris A
    J Electrocardiol; 2015; 48(5):840-4. PubMed ID: 26152604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of DOACs vs acenocoumarol in patients undergoing catheter ablation of atrial fibrillation.
    Vlachos K; Efremidis M; Bazoukis G; Letsas KP; Saplaouras A; Georgopoulos S; Karamichalakis N; Rokiza A; Sakellaropoulou A; Kolokathis AM; Efremidis T; Asvestas D; Sideris A
    Clin Cardiol; 2017 Oct; 40(10):847-852. PubMed ID: 28561951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uninterrupted vs. interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation: a prospective randomized single-centre study on post-ablation thrombo-embolic and haemorrhagic events.
    Nakamura K; Naito S; Sasaki T; Take Y; Minami K; Kitagawa Y; Motoda H; Inoue M; Otsuka Y; Niijima K; Yamashita E; Sugai Y; Kumagai K; Koyama K; Funabashi N; Oshima S
    Europace; 2019 Feb; 21(2):259-267. PubMed ID: 29982562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical comparative study regarding interrupted and uninterrupted dabigatran therapy during perioperative periods of cryoballoon ablation for paroxysmal atrial fibrillation.
    Nakamura R; Okishige K; Shigeta T; Nishimura T; Kurabayashi M; Yamauchi Y; Sasano T; Hirao K
    J Cardiol; 2019 Aug; 74(2):150-155. PubMed ID: 31029455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants.
    Brinkmeier-Theofanopoulou M; Tzamalis P; Wehrkamp-Richter S; Radzewitz A; Merkel M; Schymik G; van Mark G; Bramlage P; Schmitt C; Luik A
    BMC Cardiovasc Disord; 2018 Apr; 18(1):71. PubMed ID: 29703158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation.
    Maddox W; Kay GN; Yamada T; Osorio J; Doppalapudi H; Plumb VJ; Gunter A; McElderry HT
    J Cardiovasc Electrophysiol; 2013 Aug; 24(8):861-5. PubMed ID: 23577951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.
    Calkins H; Willems S; Gerstenfeld EP; Verma A; Schilling R; Hohnloser SH; Okumura K; Serota H; Nordaby M; Guiver K; Biss B; Brouwer MA; Grimaldi M;
    N Engl J Med; 2017 Apr; 376(17):1627-1636. PubMed ID: 28317415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation.
    Rillig A; Lin T; Plesman J; Heeger CH; Lemes C; Metzner A; Mathew S; Wissner E; Wohlmuth P; Ouyang F; Kuck KH; Tilz RR
    J Cardiovasc Electrophysiol; 2016 Feb; 27(2):147-53. PubMed ID: 26464027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
    Lakkireddy D; Reddy YM; Di Biase L; Vallakati A; Mansour MC; Santangeli P; Gangireddy S; Swarup V; Chalhoub F; Atkins D; Bommana S; Verma A; Sanchez JE; Burkhardt JD; Barrett CD; Baheiry S; Ruskin J; Reddy V; Natale A
    J Am Coll Cardiol; 2014 Mar; 63(10):982-8. PubMed ID: 24412445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban.
    Winkle RA; Mead RH; Engel G; Kong MH; Patrawala RA
    Europace; 2014 Oct; 16(10):1443-9. PubMed ID: 25115168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation.
    Kim JS; She F; Jongnarangsin K; Chugh A; Latchamsetty R; Ghanbari H; Crawford T; Suwanagool A; Sinno M; Carrigan T; Kennedy R; Saint-Phard W; Yokokawa M; Good E; Bogun F; Pelosi F; Morady F; Oral H
    Heart Rhythm; 2013 Apr; 10(4):483-9. PubMed ID: 23237911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of periprocedural anticoagulation strategies on complication rate and hospital stay in patients undergoing catheter ablation for persistent atrial fibrillation.
    Gunawardene M; Willems S; Schäffer B; Moser J; Akbulak RÖ; Jularic M; Eickholt C; Nührich J; Meyer C; Kuklik P; Sehner S; Czerner V; Hoffmann BA
    Clin Res Cardiol; 2017 Jan; 106(1):38-48. PubMed ID: 27435077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left atrial thrombus and dense spontaneous echocardiographic contrast in patients on continuous direct oral anticoagulant therapy undergoing catheter ablation of atrial fibrillation: Comparison of dabigatran, rivaroxaban, and apixaban.
    Wu M; Gabriels J; Khan M; Shaban N; D'Amato S; Liu CF; Markowitz SM; Ip JE; Thomas G; Singh P; Lerman B; Patel A; Cheung JW
    Heart Rhythm; 2018 Apr; 15(4):496-502. PubMed ID: 29605015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimally interrupted novel oral anticoagulant versus uninterrupted vitamin K antagonist during atrial fibrillation ablation.
    De Heide J; Vroegh CJ; Bhagwandien RE; Wijchers SA; Szili-Torok T; Zijlstra F; Lenzen MJ; Yap SC
    J Interv Card Electrophysiol; 2018 Dec; 53(3):341-346. PubMed ID: 30074120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uninterrupted direct oral anticoagulants vs. uninterrupted vitamin K antagonists during catheter ablation of non-valvular atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials.
    Romero J; Cerrud-Rodriguez RC; Diaz JC; Michaud GF; Taveras J; Alviz I; Grupposo V; Cerna L; Avendano R; Kumar S; Kirchhof P; Natale A; Di Biase L
    Europace; 2018 Oct; 20(10):1612-1620. PubMed ID: 29982383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate post-procedure bridging with unfractioned heparin versus low molecular weight heparin in patients undergoing radiofrequency ablation for atrial fibrillation with an interrupted oral anticoagulation strategy.
    Loughlin G; Romaniega TD; Garcia-Fernandez J; Calvo D; Salgado R; Alonso A; Li X; Arenal A; González-Torrecilla E; Atienza F; Fernández-Avilés F
    J Interv Card Electrophysiol; 2016 Mar; 45(2):149-58. PubMed ID: 26739484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Minimally Interrupted Dabigatran vs Uninterrupted Warfarin Therapy in Adults Undergoing Atrial Fibrillation Catheter Ablation: A Randomized Clinical Trial.
    Nogami A; Harada T; Sekiguchi Y; Otani R; Yoshida Y; Yoshida K; Nakano Y; Nuruki N; Nakahara S; Goya M; Origasa H; Kihara Y; Hirao K; Aonuma K;
    JAMA Netw Open; 2019 Apr; 2(4):e191994. PubMed ID: 31002317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of periprocedural dabigatran in patients undergoing catheter ablation of atrial fibrillation.
    Kaseno K; Naito S; Nakamura K; Sakamoto T; Sasaki T; Tsukada N; Hayano M; Nishiuchi S; Fuke E; Miki Y; Nakamura K; Yamashita E; Kumagai K; Oshima S; Tada H
    Circ J; 2012; 76(10):2337-42. PubMed ID: 22785434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.